RECRUITING

Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this research study is to determine if taking tamsulosin preoperatively decreases your chances of being discharged after surgery with a Foley catheter (flexible tube that drains urine from the bladder into a collection bag).

Official Title

Peri-operative Tamsulosin and Impact on Voiding Trial Following Outpatient Urogynecology Surgery: a Randomized Controlled Trial

Quick Facts

Study Start:2025-02-03

Study Completion:2026-06-01

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06843538

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:FEMALE

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
Age 18 years or older Willing and able to provide informed consent Able to understand and follow study procedures Stable medical condition	* Any surgery involving a non-urogynecologist * Patients already on an alpha blocker * Baseline hypotension * History of syncope * Postural orthostatic tachycardia syndrome (POTS) * Non-English speaker or interpreter unavailable for Spanish-speaking patient * Impaired cognition impeding proper consenting * Any other medical contraindication for tamsulosin use * History of urinary retention requiring continuous or intermittent catheterization * Patients consented for the study but then due to intraoperative complication, routine voiding trial no longer indicated due to requiring indwelling catheter or intermittent catheterization on discharge will be excluded from primary outcome analysis * Pregnancy

Inclusion Criteria

Exclusion Criteria

Age 18 years or older
Willing and able to provide informed consent
Able to understand and follow study procedures
Stable medical condition

* Any surgery involving a non-urogynecologist
* Patients already on an alpha blocker
* Baseline hypotension
* History of syncope
* Postural orthostatic tachycardia syndrome (POTS)
* Non-English speaker or interpreter unavailable for Spanish-speaking patient
* Impaired cognition impeding proper consenting
* Any other medical contraindication for tamsulosin use
* History of urinary retention requiring continuous or intermittent catheterization
* Patients consented for the study but then due to intraoperative complication, routine voiding trial no longer indicated due to requiring indwelling catheter or intermittent catheterization on discharge will be excluded from primary outcome analysis
* Pregnancy

Contacts and Locations

Study Contact

Gisele C Moran, MD, MPH

CONTACT

513-862-1123

gisele_moran@trihealth.com

Study Locations (Sites)

TriHealth

Cincinnati, Ohio, 45220

United States

Collaborators and Investigators

Sponsor: TriHealth Inc.

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-02-03

Study Completion Date2026-06-01

Study Record Updates

Study Start Date2025-02-03

Study Completion Date2026-06-01

Terms related to this study

Additional Relevant MeSH Terms

Postoperative Urinary Retention (POUR)